Risk analysis of enfortumab vedotin: A real-world approach based on the FAERS database

Risk analysis of enfortumab vedotin: A real-world approach based on the FAERS database

Purpose: To analyze the risk of enfortumab vedotin (EV), a targeted therapy for advanced bladder cancer, using real-world data from the U.S. Food and Drug Administration's Federal Adverse Event Reporting System (FAERS). Methods: A retrospective pharmacovigilance analysis was conducted using FAE...

Full description

Bibliographic Details
Main Authors: Fuchun Zheng, Yuanzhuo Du, Yuyang Yuan, Zhipeng Wang, Sheng Li, Situ Xiong, Jin Zeng, Yifan Tan, Xiaoqiang Liu, Songhui Xu, Bin Fu, Wei Liu
Format: Article
Language:English
Published: Elsevier 2024-09-01
Series:Heliyon
Subjects:
Enfortumab vedotin
Adverse events
FAERS
Real-world data analysis
Pharmacovigilance
Online Access:http://www.sciencedirect.com/science/article/pii/S240584402413575X

Internet

http://www.sciencedirect.com/science/article/pii/S240584402413575X

Similar Items